Author

Lu Zhai

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Real-world safety signals of fezolinetant in women with menopausal vasomotor symptoms: a pharmacovigilance analysis of the WHO VigiAccess database.

OBJECTIVES To characterize the real-world safety profile of fezolinetant, a neurokinin-3 receptor antagonist approved for the treatment of menopausal vasomotor symptoms, using adverse event reports from the WHO VigiAccess database. METHODS Adverse event reports were retrieved from VigiAccess. Disproportionality analy...

Yan Li, Lu Zhai, Limantian Wang et al. · Menopause · 0 citations

Review Sep 2026

Linking disease severity and mortality in obstructive sleep apnea: the role of the endothelial activation and stress index.

EASIX is associated with both mortality and disease severity in OSA, suggesting its potential as a practical biomarker for risk stratification and integrated clinical assessment.

Shu-Dan Deng, Hui-Yan Niu, Yan Li et al. · European archives of oto-rhi... · 0 citations

Sep 2026

Mechanistic insights into di(2-ethylhexyl) phthalate exposure in obstructive sleep apnea: network toxicology and in vitro validation.

Increased DEHP exposure was significantly associated with a higher risk of all-cause mortality in OSA patients, with a non-linear dose-response relationship.

Yan Li, Da-Peng Yin, Shu-Dan Deng et al. · Bioorganic chemistry (Print) · 0 citations